Proxima Centauris

Proxima is an AI-native biotech company developing proximity-based medicines and the data/AI infrastructure to rationally design them. The company, formerly known as VantAI, focuses on programmable control of protein-protein interactions through proximity-modulating small molecules, including molecular glue-like and PROTAC-related approaches. Its platform combines proteome-scale structural data generation through NeoLink with proprietary Neo AI models to support end-to-end discovery of new therapeutics for historically hard-to-drug targets. Proxima is based in New York and Boston, remains private, and is advancing an internal preclinical pipeline while also partnering with biopharma companies.